TickerGuard
Buy Day today: Neutral (52) Mixed market breadth · major macro event coming up
PMN

ProMIS Neurosciences Inc.

Healthcare · Biotechnology

10.90$ +2.0% vs. previous close Closing price · As of: Sep 30, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow PMN
Line item 2013 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – – – – – – – – – – –
– -62.8% -9.8% +6.9% -7.7% +74.8% +83.7% +195.4% -67.6% +40.4% -100.0% –
– -22.8% +5.9% +29.8% +42.9% -18.0% -36.0% +24.4% +27.1% -58.6% +204.1% +3.9%
– – – – – -39.8% -36.0% +240.4% -427.9% – – –
– – – -187.8% – +153.5% -4.5% -302.1% – -59.4% -498.3% –
– -100.0% – -100.0% – +1,993,771.6% +0.0% -94.4% -56.5% -100.0% – –
– +1,378.7% -99.5% +7.2% -7.4% +37.7% +53,686.5% – -102.8% -49.3% -48.6% +1.3%
– – – – – – – – – – – –
– – – – – +0.0% +0.0% +0.0% -100.0% – – –
– +42.3% -2.5% +203.3% +29.2% -21.8% -28.5% +568.5% -66.0% +103.4% +57.1% -24.9%
– +2,547.5% -122.5% – -33.9% -241.7% – – -192.0% – -89.7% -1,135.3%
– – – – – – – – – – – –

Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?